Genetic Technologies Limited (GENE) Sof foyda bo'yicha sotuv rentabelligi

GENE (gtglabs.com) - kompaniyaning tovar belgisi

Genetic Technologies o'zining noyob GeneType testlari orqali daromad oqimlarini yaratadi, bu testlar diabet va saratonni oldindan aniqlash imkonini beradi. Sof foyda marjasi daromadli tendentsiyani tasdiqlaydi, bunda -156.80 eng so'nggi metrika ko'rsatkichini ifodalaydi. Kompaniya sug'urta sektori orqali B2B savdolarini kengaytirmoqda va patologiyalarni erta aniqlash uchun poligenik xavf ballarini shaxsiylashtirilgan tibbiyot standartlariga integratsiya qilishni maqsad qilgan.

gtglabs.com (GENE) - Kompaniya sotuv marjasi 04.07.2022dan 26.10.2024gacha

Genetic Technologies Ltd (GENE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning fundamental baholanishi:Genetic Technologies Ltd - GENE
Genetic Technologies Limited tayyor mahsulotlari

Sotuv marjasi jami daromadning sof foyda ulushini aks ettiradi va daromadning yakuniy kapitalga aylanish samaradorligini o'lchaydi. Investorlar ushbu ko'rsatkichdan biznesning operatsion xarajatlar va inflyatsion zarbalarga nisbatan barqarorligini baholash uchun foydalanadilar. Yakuniy sotuv marjasini tahlil qilish orqali Genetic Technologies (GENE) daromadliligining xizmatlar miqyosini kengaytirishga bog'liqligini kuzatish mumkin. Joriy foyda tebranishlari genetik testlarni AQSh va Avstraliya tibbiy protokollariga integratsiya qilish jarayoni bilan bevosita bog'liqdir. Ushbu ko'rsatkichning o'sishi kompaniya modelining tijorat jihatidan hayotiyligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

A (Agilent Technologies) - Sof foyda bo'yicha sotuv rentabelligi|DGX: Kompaniyaning sof rentabelligi|Sof marja Illumina Platform|EXAS (Exact Sciences) - Kompaniyaning sof rentabelligi|Sof foyda bo'yicha sotuv rentabelligi RVTY (PerkinElmer)|Bio-Rad - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi NNNN (Anbio)|Sof foyda normasi SHC|QDEL - Sof marja|OPK: Sof marja|caredx.com (CDNA) - Sof marja|MRVI (Maravai LifeSciences) - Sof marja|FLGT (Fulgent) - Sotuvning sof marjinal rentabelligi|Standard BioTools Inc (LAB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CTKB|Sof foyda bo'yicha sotuv rentabelligi OraSure Technologies Inc OSUR|Sotuvning sof marjinal rentabelligi XGN (Exagen Diagnostics)|Sotuvning sof marjinal rentabelligi mdxhealth.com MDXH|LUCD - Sof marja|PRE: Sof marja|IMDX (Insight Molecular Diagnostics Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Trinity Biotech PLC|PRPH (prophaselabs.com) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Ainos, Inc. (AIMD)|Sotuvning sof marjinal rentabelligi CODX|HSCS (HeartSciences) - Sof foyda normasi|Sof marja Biomerica, Inc BMRA|CDIO - Sof foyda bo'yicha sotuv rentabelligi|ONCO - Sof marja|VRAX - Sotuvning sof marjinal rentabelligi|Bluejay Diagnostics Inc (BJDX) - Sof marja|Aspira Women's Health Inc. - Sof foyda normasi|AXDX (Accelerate Diagnostics Inc) - Sotuvning sof marjinal rentabelligi|Sof marja Centogene N.V. CNTG|Sotuvning sof marjinal rentabelligi ENZ|Sof marja FRES (Fresh2)|Sotuvning sof marjinal rentabelligi ME (23andme.com)|Psychemedics Corp. (PMD) - Sof marja